# Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM Constitutional Types: A Prospective Cohort Study

> **NCT07741903** · — · NOT_YET_RECRUITING · sponsor: **Affiliated Hospital of Chengde Medical University** · enrollment: 500 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07741903
- **Lead sponsor:** Affiliated Hospital of Chengde Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741903, "Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM Constitutional Types: A Prospective Cohort Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*